{"id":"NCT04537234","sponsor":"Sanofi Pasteur, a Sanofi Company","briefTitle":"Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Taiwanese Adults 65 Years of Age and Older","officialTitle":"Immunogenicity and Safety of a High-Dose Quadrivalent Influenza Vaccine in Subjects 65 Years of Age and Older in Taiwan","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-11-10","primaryCompletion":"2021-02-09","completion":"2021-02-09","firstPosted":"2020-09-03","resultsPosted":"2021-11-08","lastUpdate":"2022-04-07"},"enrollment":165,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Influenza (Healthy Volunteers)"],"interventions":[{"type":"BIOLOGICAL","name":"High-Dose Quadrivalent Influenza Vaccine","otherNames":["Fluzone® High Dose, Efluelda™"]},{"type":"BIOLOGICAL","name":"Standard-Dose Quadrivalent Influenza Vaccine","otherNames":["AdimFlu-S (QIS)"]}],"arms":[{"label":"Group 1: High-Dose Quadrivalent Influenza Vaccine (QIV-HD)","type":"EXPERIMENTAL"},{"label":"Group 2: Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD)","type":"ACTIVE_COMPARATOR"}],"summary":"Primary Objective:\n\nImmunogenicity: To describe the immune response induced by high-dose quadrivalent influenza vaccine (QIV-HD) and AdimFlu-S (QIS) by hemagglutinin inhibition (HAI) measurement method in all participants.\n\nSafety: To describe the safety profile of all participants in each study groups.","primaryOutcome":{"measure":"Geometric Mean Titers (GMTs) of Influenza Vaccine Antibodies at Day 0","timeFrame":"Day 0 (pre-vaccination)","effectByArm":[{"arm":"Group 1: High-Dose Quadrivalent Influenza Vaccine (QIV-HD)","deltaMin":23.6,"sd":null},{"arm":"Group 2: Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD)","deltaMin":24.1,"sd":null}],"pValues":[]},"eligibility":{"minAge":"65 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":2,"exclusionCount":14},"locations":{"siteCount":4,"countries":["Taiwan"]},"refs":{"pmids":["36216650"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":82},"commonTop":["Injection Site Pain","Myalgia","Malaise","Injection Site Erythema","Headache"]}}